IBO
Impact BioMedical, Inc.
stockNYSEAMERICAN
At CloseOct 20, 2026 3:48:47 PM EDT
3.42USD+12.500%(+0.38)12,331
IBO Financials
In Q2 FY 2026 (ended ), Impact BioMedical, Inc. (IBO) reported revenue of $3K, net income of −$699K, operating cash flow of $470K, and assets of $16.75M.
Loading financial flows…